People with diabetes who undergo cancer surgery are more likely to die in the month following their operations than those who have cancer but not diabetes, an analysis by Johns Hopkins researchers suggests.
Joslin scientists find surprising twist in PI 3-kinase molecule that may offer novel target for diabetes drugs.
Millions of Americans may have chronic kidney disease (CKD) and not know it, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
Researcher exploring link between gastric bypass surgery and rapid, profound positive effect on Type II diabetes.
Using leptin alone in place of standard insulin therapy shows promise in abating symptoms of type 1 diabetes, UT Southwestern Medical Center researchers report.
Pediatric researchers analyzing DNA variations in type 1 diabetes and inflammatory bowel disease have found a complex interplay of genes. Some genes have opposing effects, raising the risk of one disease while protecting against the other. In other cases, a gene variant may act in the same direction, raising the risk for both diseases.
Salsalate, an anti-inflammatory agent, shows encouraging results in preliminary trial led by Joslin Diabetes Center.
An experimental oral drug has lowered blood sugar levels and inflammation in mice with Type 2 diabetes, suggesting that the medication could someday be added to the arsenal of drugs used by millions of Americans with this disease, according to new research.
Purchases of cholesterol and diabetes prescription drugs by elderly Medicare beneficiaries reached nearly $19 billion in 2007 – about one-fourth of the approximately $82 billion spent for medications for the elderly.
A new study shows that primary care physicians believe the barriers that put patients with uncontrolled diabetes at risk for cardiovascular disease as being patient-related or system-related. Published online today by the Journal of the American Board of Family Medicine by researchers at UMDNJ-Robert Wood Johnson Medical School and colleagues at the University of Hawaii and University of Michigan, the research also reports that the physician participants commonly reported a high level of frustration at being unable to motivate patients with poor control or help patients to overcome the barriers that inhibit healthier lifestyles.
Measurements of hemoglobin A1c (HbA1c) more accurately identify persons at risk for clinical outcomes than the commonly used measurement of fasting glucose, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health. HbA1c levels accurately predict future diabetes, and they better predict stroke, heart disease and all-cause mortality as well. The study appeared in the March 4, 2010, issue of New England Journal of Medicine.
A Cedars-Sinai Heart Institute cardiologist co-authored the joint science advisory issued by the American Heart Association and the American College of Cardiology that calls for close monitoring of patients taking certain blood sugar-lowering drugs.
On March 1, the first eye patients will enter a new $132 million facility that increases the University of Michigan Health System's capacity to provide advanced eye care for an aging population and unites diabetes researchers as they search for a cure for diabetes. The eight-story Brehm Tower at the W.K. Kellogg Eye Center Complex makes a striking addition to the skyline. Because of the size of the expansion and to get new research projects up and running, Kellogg expects to add about 100 jobs over the next five to seven years.
Dr. Francesco Rubino, chief of gastrointestinal metabolic surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, is now enrolling overweight and mildly obese patients -- those with a body mass index (BMI) of 28 to 35 -- in a study of gastric bypass surgery aimed at reversing Type 2 diabetes. Because of their non-morbidly obese status, these patients do not qualify for the surgery under current guidelines.
The drug avosentan substantially reduces urinary protein loss in people with type 2 diabetes and kidney disease, but the drug causes serious side effects, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results suggest that lower doses of avosentan may have a more favorable risk/benefit ratio for patients.
An international group of medical experts has crafted a much-needed classification system for diabetic nephropathy, the leading cause of total kidney failure, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The effort should improve communication among health professionals, help researchers design better clinical studies, and guide patient care.
Finding by Joslin Diabetes Center scientists may aid in understanding how insulin production eventually goes wrong in type 2 diabetes.
A team of Northern Arizona University-led researchers is using nearly $1.3 million in new funding from the National Institutes of Health to continue with the world’s longest-running study on obesity and Type 2 diabetes.
Diabetic retinopathy remains the major cause of blindness in adults under 60 in the U.S. The disease affects 5.3 million adults in the U.S. and some 24,000 of them go blind each year. Nearly sixty percent of all diabetes patients are expected to develop diabetic retinopathy within ten years of their diagnosis.
Ethnic and racial minorities bear a disproportionate share of America’s diabetes epidemic but are significantly less likely than whites to receive a commonly used test to monitor control of blood glucose, according to Washington State University researchers.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right